🔴 Optimi Health is trading 15.6% down today with no clear company-specific catalyst identified

Optimi Health is trading at $2.11 (-15.59%), with no clear company-specific announcement identified to explain the November 2 decline.

• Biotechnology shares are also lower: XBI was down 1.81% at 1:00 p.m. ET, supporting sector pressure as context.
• The drop is much larger than the sector move, and available evidence does not establish a separate company-specific cause.
• The latest reported MDMA production update concerns supply for clinical programs and Australia, not a new catalyst today.